EyePoint Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
32.33
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.70
|
-0.49
|
0.21
|
30.00%
|
|
2022-06-30
|
-0.52
|
-0.52
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.58
|
-0.56
|
0.02
|
3.45%
|
|
2021-12-31
|
-0.53
|
-0.59
|
-0.06
|
-11.32%
|
|
2021-09-30
|
-0.40
|
-0.58
|
-0.18
|
-45.00%
|
|
2021-06-30
|
-0.43
|
-0.35
|
0.08
|
18.60%
|
|
2021-03-31
|
-0.46
|
-0.50
|
-0.04
|
-8.70%
|
|
2020-12-31
|
-0.17
|
-1.07
|
-0.90
|
-529.41%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.57
|
|
2021-12-31
|
-2.02
|
|
2020-12-31
|
-3.47
|
|
2019-12-31
|
-5.60
|
|
2018-12-31
|
-2.41
|
|
2017-12-31
|
-0.59
|
|
2016-12-31
|
-0.55
|
|
2015-12-31
|
-0.69
|
|
2014-12-31
|
0.31
|
|
2013-12-31
|
-0.56
|
|
2012-12-31
|
-0.46
|
|
2011-12-31
|
-0.39
|
|
2010-12-31
|
6.34
|
|
2009-12-31
|
-1.52
|
|
2008-12-31
|
-47.78
|
|
2007-12-31
|
-14.48
|